Abstract
Dr. Guido Zaman is Section Head Molecular in the Pharmacology Unit of N.V. Organon in Oss, the Netherlands. His section is responsible for assay development from cDNA to HTS, and in vitro biological testing from hit to clinical candidate. Guido completed his PhD in molecular biology on protein - RNA interaction at the University of Nijmegen in 1991, and studied multidrug resistance of human cancer cells at the Netherlands Cancer Institute in Amsterdam before joining Organon in 1996. In addition to serving as a guest editor of the mini-hot topic in this issue, Guido Zaman is a member of the Editorial Board of Assay & Drug Development Technologies.
Related Journals
Current Computer-Aided Drug Design
13